That is the paraphrased title of a paper by Fusco et al. (2023). The authors conduct a scientific literature overview of research printed between 2010 and 2020 and discover that among the many 79 articles screened:
Nearly all of publications discovered that, no matter illness space, elevated cost-sharing was related to worse adherence, persistence, or discontinuation. The combination knowledge urged the larger the magnitude of cost-sharing, the more severe the adherence. Amongst research inspecting medical outcomes, cost-sharing was related to worse outcomes in 1 research and the remaining 3 discovered no vital variations. Relating to HRU [healthcare resource utilization], higher-cost-sharing trended towards decreased outpatient and elevated inpatient utilization. The out there proof urged increased cost-sharing has an general impartial to unfavorable influence on complete prices. Research evaluating elimination of copays discovered both decreased or no influence in complete prices.
There are two problem with the paper (i) publication bias and (ii) price sharing measurement. With respect to the previous, are papers that present no relationship between price sharing and adherence, HRU and value much less more likely to be printed? Probably. Whereas this bias possible would influence the purpose estimates, it appears logically and empirically very robust that increased price sharing reduces adherence and will increase inpatient admissions. Publication bias could also be extra influential for the opposite outcomes measured (i.e., medical outcomes and value). The second problem is that price sharing could also be measured in several methods throughout research. The authors do point out that the kind and magnitude of price sharing diversified throughout research. Extra importantly, nonetheless, the connection between price sharing and outcomes is troublesome to estimate empirically since what one wish to measure is the price sharing construction a affected person faces; for those who don’t fill a drug as a result of price sharing is just too excessive, noticed copayments within the knowledge shall be $0 however the true price sharing one faces is giant. Alternatively, if an individual has low price sharing, they could determine the fill the drug and noticed price sharing (as measured in claims) can be excessive even when the profit design may be very beneficiant. Since claims knowledge solely embody quantities paid reasonably than a affected person’s profit construction, artistic econometric options–or knowledge that mix claims and profit design–are wanted to estimate the connection between price sharing and value in a extra rigorous method. However, by conducting a scientific literature overview of those research, Fusco and co-authors have supplied an essential overview for researchers to guage these points for particular person research in additional element.